Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$147.1K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Mar 18 | STOK | Stoke Therapeutics, Inc. | SSELL | 2,173 | $31.28 | $68K | -17.3% | Open the original filing on SEC.gov |
| Mar 17 | STOK | Stoke Therapeutics, Inc. | SSELL | 922 | $33.38 | $30.8K | -6.8% | Open the original filing on SEC.gov |
| Mar 17 | STOK | Stoke Therapeutics, Inc. | SSELL | 1,274 | $32.74 | $41.7K | -8.6% | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 14,750 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER | 14,750 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 40,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 60,000 | — | — | — | Open the original filing on SEC.gov |